Aigen Investment Management, LP

Position in INCY — Incyte Corp

CIK 1741224 NEW YORK, NY

Position in INCY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,671,101

+$2,305,696 QoQ

Shares Held

23,563

+267.4% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.73%

of 13F equity value

Holder Rank

#299

of 854 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Aigen Investment Management, LP holds $12,762,383 across 22 Biotechnology names. INCY ranks #2 (20.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	7,452	$3,701,631
2	INCY	Incyte Corp This page	23,563	$2,671,101
3	INSM	INSMED Inc	16,847	$1,796,227
4	ASND	Ascendis Pharma A/S	4,073	$1,086,350
5	AXSM	Axsome Therapeutics, Inc.	2,390	$585,000
6	SMMT	Summit Therapeutics Inc.	24,477	$356,629
7	JANX	Janux Therapeutics, Inc.	22,841	$350,837
8	XENE	Xenon Pharmaceuticals Inc.	5,218	$314,958

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,671,101	23,563	+267.4%	Shares	Sole	2026-08-14
2024-03-31	$365,405	6,414	-24.6%	Shares	Sole	2024-05-14
2023-12-31	$533,903	8,503	-20.5%	Shares	Sole	2024-02-09
2023-09-30	$617,792	10,694	-85.3%	Shares	Sole	2023-11-13
2023-06-30	$4,543,627	72,990	+2.0%	Shares	Sole	2023-08-14
2022-12-31	$5,747,056	71,552	+232.9%	Shares	Sole	2023-02-10
2021-09-30	$1,478,357	21,494	-70.2%	Shares	Sole	2021-11-12
2021-06-30	$6,068,128	72,128	+161.6%	Shares	Sole	2021-08-10
2021-03-31	$2,240,451	27,568	+288.2%	Shares	Sole	2021-05-11
2020-12-31	$617,644	7,101	+116.2%	Shares	Sole	2021-02-12
2020-09-30	$294,795	3,285	-60.0%	Shares	Sole	2020-11-06
2020-06-30	$853,281	8,207	-42.6%	Shares	Sole	2020-08-10
2020-03-31	$1,047,774	14,308	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.